Decoy Therapeutics Inc logo

Decoy Therapeutics Inc

NEW
FRA:FP11 (USA)  
€ 5.23 (0%) Jul 2
At Loss
P/B:
1.01
Market Cap:
€ 3.42M ($ 3.91M)
Enterprise V:
€ 1.93M ($ 2.21M)
Volume:
0
Avg Vol (2M):
0
Trade In:

GF Valueâ„¢

Decoy Therapeutics Inc’s share price is €5.232. Its GF Value is €0. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Decoy Therapeutics Inc stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: €5.232 GF Value Price/GF Value
Current €0 Infinity
Next FY1 End €0 Infinity
Next 12 Month €0 Infinity
Next FY2 End €0 Infinity
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Decoy Therapeutics Inc's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Decoy Therapeutics Inc's stock price and Book Value per share, with a coefficient of 94%. Decoy Therapeutics Inc’s stock price shows no significant correlation with Earnings without NRI per share. Decoy Therapeutics Inc’s stock price shows no significant correlation with Operating Cash Flow per share. Decoy Therapeutics Inc’s stock price shows no significant correlation with Revenue per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies